A Phase 1b and Pharmacodynamic Study of Nintedanib Monotherapy for Advanced Pancreatic Cancer
Phase of Trial: Phase I/II
Latest Information Update: 07 Mar 2018
At a glance
- Drugs Gemcitabine (Primary) ; Nintedanib (Primary) ; Paclitaxel (Primary)
- Indications Adenocarcinoma; Pancreatic cancer
- Focus Adverse reactions
- 27 Feb 2018 Planned End Date changed from 1 Sep 2019 to 1 Sep 2020.
- 27 Feb 2018 Status changed from not yet recruiting to recruiting.
- 22 Nov 2016 Planned initiation date changed from 1 Sep 2016 to 1 Jan 2017.